Skybiotech Healthcare (BOM:512036) Other Current Receivables: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512036 Skybiotech Healthcare Ltd BOM:512036
24 GF Score
Price ₹124.20
! 5 Warning Signs
View Full Analysis

What is Skybiotech Healthcare Other Current Receivables?

Skybiotech Healthcare BOM:512036 +0.16% 24 Other Current Receivables is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:512036 with a GF Score™ of 24/100. The stock has 5 warning signs investors should review.

Skybiotech Healthcare's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Skybiotech Healthcare's annual Other Current Receivables stayed the same from Mar. 2024 (₹0.00 Mil) to Mar. 2025 (₹0.00 Mil) but then increased from Mar. 2025 (₹0.00 Mil) to Mar. 2026 (₹0.11 Mil).

Skybiotech Healthcare Other Current Receivables Related Terms

Skybiotech Healthcare Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Skybiotech Healthcare's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skybiotech Healthcare Other Current Receivables Chart

Skybiotech Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.11

Skybiotech Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.23 0.00 0.11 0.00
BOM:512036
24GF Score
Skybiotech Healthcare Ltd BOM:512036
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skybiotech Healthcare Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0.00 Mil mean?
Skybiotech Healthcare (BOM:512036) has a Other Current Receivables of ₹0.00 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Skybiotech Healthcare and its competitors.
Is Skybiotech Healthcare's Other Current Receivables too high?
Skybiotech Healthcare's current Other Current Receivables is ₹0.00 Mil. Overall, Skybiotech Healthcare has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Skybiotech Healthcare's Other Current Receivables compare to MMM and HON?
Skybiotech Healthcare's Other Current Receivables of ₹0.00 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Conglomerates company?
A good Other Current Receivables depends on the Conglomerates industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Skybiotech Healthcare and its competitors. Skybiotech Healthcare's current Other Current Receivables is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skybiotech Healthcare stock overvalued right now?
Skybiotech Healthcare (BOM:512036) has a current Other Current Receivables of ₹0.00 Mil. The current Other Current Receivables is ₹0.00 Mil. Skybiotech Healthcare's overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Skybiotech Healthcare (BOM:512036), the current Other Current Receivables is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skybiotech Healthcare Business Description

Address Paithan Road, Gevrai Tanda, Gut No. 05, Chhatrapati Sambhaji Nagar, MH, IND, 431002
Skybiotech Healthcare Ltd, formerly Kapil Cotex Ltd is engaged in textiles and allied products, including dyeing, printing, spinning, weaving, and manufacturing fabrics from raw cotton. During the year under review, the company has not generated any revenue from its core business activities. Instead, it earned income from consultancy services for foreign clients and from investments in shares, generating capital gains and dividends. The company's current revenue mainly comes from these non-core activities rather than textile manufacturing.
24GF Score

Get the complete analysis for BOM:512036

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹124.20
Price